GSK : and ViiV Healthcare to present scientific advancements in their industry-leading infectious diseases portfolio at IDWeek 2023 -October 10, 2023 at 07:17 am EDT

First scientific presentation of RSV vaccine efficacy and safety data over two seasons


New public health impact modelling study data on meningococcal B...

Related Keywords

United States ,Buenos Aires ,Distrito Federal ,Argentina ,China ,United Kingdom ,Geneva ,Genè ,Switzerland ,Japan ,Boston ,Massachusetts ,Great Britain ,American ,Chinese ,Florian Wagenlehner ,Andrewp Brogan ,Teriya Richmond ,Tony Wood ,Jamilak Williams ,Charlotte Paigem Rolle ,William Valenti ,Debral Fromer ,Tonia Poteat ,Thomasm Hooton ,Shaloo Gupta ,Judith Breuer ,Sj Ryan Arends ,Alftan Dyson ,Aimeea Metzner ,Mehris Mckellar ,Samir Gupta ,Rickyk Hsu ,Gary Sinclair ,Helena Kwakwa ,Maria Acosta ,Ahmed Salem ,Juliana Torres ,Tomas Kierszenowicz ,Zeki Kocaata ,Jennifer Moore ,Jeffreyj Ellis ,Shahina Begum ,Davinder Dosanjh ,Dima Dandachi ,Deanna Kerrigan ,Richarda Elion ,Christopher Bell ,Meg Franklin ,Wendy Davis ,Oscar Herrera Restrepo ,Eliana Biundo ,Cindy Garris ,Global Health ,Department Of Veterans Affairs Health System ,Infectious Disease Society Of America Idweek ,National Immunization ,Shionogi Co Ltd ,World Health Organization ,Pfizer Inc ,A Public Health Impact Modelling Study ,Viiv Healthcare ,Infectious Disease Society ,Respiratory Syncytial Virus ,Chief Scientific Officer ,Systematic Literature Review ,Disparities That May Influence Health Equity ,Invasive Meningococcal Disease Prevention ,Qualitative Study ,Caregiver Preferences ,Vaccination Coverage Disparities ,Immunization Survey Teen Data ,Added Gonorrhea Protection ,Public Health Impact Modelling Study ,Meningococcal Disease Vaccination ,Targeted Literature Review ,Vaccine Preventable Disease Hospitalisations ,Ageing Population ,Chronic Comorbidities ,Health Equity Related Public Impact ,National Immunisation Programmes ,One Dose ,Prefusionf Protein Vaccine ,Herpes Zoster Among Employed Adults ,Veterans Affairs Health System ,World Effectiveness ,Recombinant Zoster Vaccine ,Chinese Adults Aged ,Uncomplicated Urinary Tract Infection ,Pooled Subgroup Analyses ,Regulatory Guidelines ,Microbiological Success Rates ,Two Phase ,Controlled Trials ,Oral Gepotidacin ,Drug Resistant Phenotypes ,Pooled Analysis ,Treatment Failure When Treated ,Empiric Oral Antibiotics Among ,Treatment Considerations ,Oral Antibiotic Treatment Failure ,Acute Uncomplicated Cystitis ,Oral Standard Of Care Antibiotics ,Urinary Tract Infections Caused By Escherichia ,Prospective Cohort Study ,Immunocompromised Non Hospitalized Patients ,Were Treated ,Different Injection Sites ,Administrative Claims Data ,Intravenous Sotrovimab Dose ,Immunocompromised Participants Uninfected ,North American ,Cabotegravir Long Acting ,Real World ,Chronic Kidney Disease ,Viral Suppression ,Treatment Adherence ,Patients Suppressed ,Fixed Dose ,Clinic Receipt ,Rilpivirine Long Acting ,Annual Report ,Health Estimates ,Global Health Estimates ,Global Disease Burden Estimates ,Older Adults ,Systematic Review ,Accessed June ,Markets ,